Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Linn

Showing results (171-180 of 467) with videos related to

Pageof 47
Sort By:
Breast Cancer Research : BCR|July 27, 2020
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancerEsther H Lips, Anne Benard-Slagter, Mark Opdam, et al.
Breast (Edinburgh, Scotland)|June 29, 2012
Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancerM Kok, R H Koornstra, S Mook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2009
A simple system for grading the response of breast cancer to neoadjuvant chemotherapyS Rodenhuis, I A M Mandjes, J Wesseling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridilS C Linn, C K van Kalken, O van Tellingen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2013
Prospective cost-effectiveness analysis of genomic profiling in breast cancerV P Retèl, M A Joore, C A Drukker, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2024
High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providersJoost G E Verbeek, Leyla Azarang, Luis E Pilli, et al.
American Journal of Surgery|December 20, 2008
Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapyMarieke E Straver, Emiel J T Rutgers, Hester S A Oldenburg, et al.
Acta Oncologica (Stockholm, Sweden)|September 9, 2008
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side studyChristina M Schilder, Petronella C Eggens, Caroline Seynaeve, et al.
Bone Marrow Transplantation|March 7, 2003
Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisisL P Koh, W Y K Hwang, C T H Chuah, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2019
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1Filippo Montemurro, Paul Ellis, Antonio Anton, et al.
Pageof 47

Showing results (171-180 of 467) with videos related to

Sort By:
Pageof 47
Breast Cancer Research : BCR|July 27, 2020
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancerEsther H Lips, Anne Benard-Slagter, Mark Opdam, et al.
Breast (Edinburgh, Scotland)|June 29, 2012
Additional value of the 70-gene signature and levels of ER and PR for the prediction of outcome in tamoxifen-treated ER-positive breast cancerM Kok, R H Koornstra, S Mook, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2009
A simple system for grading the response of breast cancer to neoadjuvant chemotherapyS Rodenhuis, I A M Mandjes, J Wesseling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Clinical and pharmacologic study of multidrug resistance reversal with vinblastine and bepridilS C Linn, C K van Kalken, O van Tellingen, et al.
European Journal of Cancer (Oxford, England : 1990)|September 3, 2013
Prospective cost-effectiveness analysis of genomic profiling in breast cancerV P Retèl, M A Joore, C A Drukker, et al.
Acta Oncologica (Stockholm, Sweden)|September 11, 2024
High-dose chemotherapy for patients with stage III breast cancer with homologous recombination deficiency: a discrete choice experiment among healthcare providersJoost G E Verbeek, Leyla Azarang, Luis E Pilli, et al.
American Journal of Surgery|December 20, 2008
Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapyMarieke E Straver, Emiel J T Rutgers, Hester S A Oldenburg, et al.
Acta Oncologica (Stockholm, Sweden)|September 9, 2008
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side studyChristina M Schilder, Petronella C Eggens, Caroline Seynaeve, et al.
Bone Marrow Transplantation|March 7, 2003
Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisisL P Koh, W Y K Hwang, C T H Chuah, et al.
European Journal of Cancer (Oxford, England : 1990)|February 2, 2019
Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1Filippo Montemurro, Paul Ellis, Antonio Anton, et al.
Pageof 47